A model for the pathophysiology of schizophrenia is proposed that focuses on an unbalance of transmission in tripartite synapses. Synaptically associated astrocytes should be viewed as integral modulatory elements of tripartite synapses consisting of the presynapse, the postsynapse, and the glial element. Astrocytes may secrete glial binding protein into the synaptic cleft, thus binding free neurotransmitters and thereby reducing the levels of neurotransmitters available for stimulating the postsynapse. Astrocytes also have membrane-bound receptors for neurotransmitters, and when these bind neurotransmitters, the astrocytes upregulate the amount of binding protein secreted into the synapse, resulting in a negative feedback to the presynaptic terminal. The hypothesis presented here is that glia lose their negative feedback function due to loss of function mutations in the genes encoding the binding proteins and glial receptors. The mutations generate proteins that cannot be occupied by their cognate substances of the neuronal system, primarily neurotransmitters. Therefore, the glial-neuronal interaction in tripartite synapses affected becomes totally unbalanced, and the glia lose their inhibitory or boundary-setting function. As a result, neural flux is unconstrained by normal glial boundaries, also the flux of thought on the phenomenological level. Schizophrenia may be caused by the inability to delimit conceptual boundaries.
Abi-Dargham A.2003. Evidence from brain imaging studies for dopaminergic alterations in schizophrenia. In: Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London: Martin Dunitz. p 15-47.
2.
American Psychiatric Association. 1998. Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association.
3.
Araque A, Parpura V, Sanzgiri RP, Haydon PG. 1999. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci22: 208-215.
4.
Auld DS, Robitaille R.2003. Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron40: 389-400.
5.
Bezzi P, Volterra A.2001. A neuron-glia signalling network in the active brain. Curr Opin Neurobiol11: 387-394.
6.
Carlsson A.2003. Historical aspects and future directions. In: Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London: Martin Dunitz. p 1-13.
7.
Carpenter WT, Buchanan RW. 1995. Schizophrenia: introduction and overview. In: Kaplan HI, Sadock BJ, editors. Comprehensive text-book of psychiatry VI, vol. 1. Baltimore: Williams and Wilkins. p 889-902.
8.
Charles A, Giaume C.2002. Intercellular calcium waves in astrocytes: underlying mechanisms and functional significance. In: Volterra A, Magistretti PJ, Haydon PG, editors. The tripartite synapse: glia in synaptic transmission. Oxford (UK): Oxford University Press. p 110-126.
9.
Davis KL, Kahn RS, Ko G, Davidson M.1991. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry148: 1474-1486.
10.
Dennett D.1987. The intentional stance. Cambridge (MA): Little, Brown.
11.
Dollfus S, Petit M.1995. Negative symptoms in schizophrenia: their evolution during an acute phase. In: Schizophrenia research, vol. 17. New York: Basic Books. p 187-194.
12.
Engel AG, Ohno K, Wang H, Milone M, Sine SM. 1998. Molecular basis of congenital myasthenic syndromes: mutations in the acetylcholine receptor. Neuroscientist4: 185-194.
13.
Fisher S, Cleveland SE. 1968. Body image and personality. New York: Dover.
14.
Frith CD. 1999. The cognitive neuropsychology of schizophrenia. East Sussex (UK): Psychology Press.
15.
Günther G. 1963. Das Bewusstsein der Maschinen. Baden-Baden (Germany): Agis-Verlag.
16.
Harrison PJ, Eastwood SL. 1998. Prefrontal involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet352: 1669-1673.
17.
Haydon PG. 2001. Glia: listening and talking to the synapse. Nat Rev Neurosci2: 185-193.
18.
Heyman I, Murray RM. 1992. Schizophrenia and neurodevelopment. J R Coll Physicians Lond26: 143-146.
Huntsman MM, Tran BV, Potkin SG, Brunney WE, Jones EG. 1998. Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A95: 15066-15071.
21.
Iberall AS, McCulloch WS. 1969. The organizing principle of complex living systems. Trans ASME6: 290-294.
22.
Johnstone EC, Humphreys MS, Lang FH, Lawrie SM, Sandler R.1999. Schizophrenia. Cambridge (UK): Cambridge University Press.
23.
Kettenmann H, Ransom BR, editors. 1995. Neuroglia. New York: Oxford University Press.
24.
Kraepelin E.1971. Dementia praecox and paraphrenia. Barclay RM, translator. New York: Robert R. Krieger.
25.
Lewis DA. 2000. Is there a neuropathology of schizophrenia? Recent findings converge on altered thalamic-prefrontal cortical connectivity. Neuroscientist6: 208-218.
26.
Maynard TM, Sikich L, Liebermann JA, LaMantia AS. 2001. Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr Bull27: 457-476.
27.
McGlashan TH, Hoffmann RE. 1995. Schizophrenia: psychodynamic to neurodynamic theories. In: Kaplan HT, Sadock BJ, editors. Comprehensive textbook of psychiatry VI, vol. 1. Baltimore: Williams and Wilkins. p 957-968.
28.
Meltzer H.2003. Multiple neurotransmitters involved in antipsychotic drug action. In: Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London: Martin Dunitz. p 177-205.
29.
Mitterauer B.1998. An interdisciplinary approach towards a theory of consciousness. Biosystems45: 99-121.
30.
Mitterauer B.2000a. Clock genes, feedback loops and their possible roles in the etiology of bipolar disorders: an integrative model. Med Hypotheses55: 155-159.
31.
Mitterauer B.2000b. Some principles for conscious robots. Journal of Intelligent Systems10: 27-56.
32.
Mitterauer B.2001a. Clocked perception system. Journal of Intelligent Systems11: 269-297.
33.
Mitterauer B.2001b. The loss of ego boundaries in schizophrenia: a neuromolecular hypothesis. Med Hypotheses56: 614-621.
34.
Mitterauer B.2003a. The eternal now: towards an interdisciplinary theory of schizophrenia. Journal of the BWW Society. Available from: http://www.bwwsociety.org/journal/html/eternalnow.htm.
35.
Mitterauer B.2003b. The loss of self-boundaries: towards a neuromolecular theory of schizophrenia. Biosystems72: 209-215.
36.
Mitterauer B.2004a. Gene silencing: a possible molecular mechanism in remission of affective disorder. Med Hypotheses62: 907-910.
37.
Mitterauer B.2004b. Imbalance of glial-neuronal interaction in synapses: a possible mechanism of the pathophysiology of bipolar disorder. Neuroscientist10: 199-208.
38.
Mitterauer B, Kopp C.2003. The self-composing brain: towards a glial-neuronal brain theory. Brain Cogn51: 357-367.
39.
Mitterauer B, Leitgeb H, Reitboeck H.1996. The neuro-glial synchronization hypothesis. Recent Research Development in Biological Cybernetics1: 137-155.
40.
Mitterauer B, Pritz WF. 1978. The concept of the self: a theory of self-observation. Int Rev Psychoanal5: 179-188.
41.
Mizukami K, Ishikawa M, Hidaka S, Iwakiri M, Sasaki M, Iritani S.2002. Immunohistochemical localization of GABA(B) receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry26: 393-396.
42.
Owen MJ, Williams NM, O’Donovan MC. 2004. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry9: 14-27.
43.
Rall W.1995. Theoretical significance of dendritic trees for neuronal input-output relations. In: Segev I, Rinzel J, Shepherd GM, editors. The theoretical foundation of dendritic function. Cambridge (MA): MIT Press. p 122-146.
44.
Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, Konnerth A.2003. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glial cells. Nature426: 74-78.
45.
Schmauss C.1996. Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci16: 7902-7909.
46.
Shastry BS. 2002. Schizophrenia: a genetic perspective. Int J Mol Med9: 207-212.
47.
Sims A.1991. An overview of the psychopathology of perception: first rank symptoms as a localizing sign in schizophrenia. Psychopathology24: 369-374.
48.
Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, and others. 2001. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature411: 261-268.
49.
Teichberg VI. 1991. Glial glutamate receptors: likely actors in brain signalling. FASEB J.5: 3086-3091.
50.
Volterra A, Magistretti P, Haydon P.2002. The tripartite synapse: glia in synaptic transmission. Oxford (UK): Oxford University Press.
51.
Werner G, Black FO, Cornes C, Larkin A, Steinhauer S.1982. Anomalies of neuro-sensory functions and representational world in schizophrenics. In: Msokir E, Handin I, editors. Biological markers in psychiatry and neurology. Oxford (UK): Pergamon.
52.
Wyatt RJ, Kirch DG, Egan MF. 1995. Schizophrenia: neurochemical, viral, and immunological studies. In: Kaplan, HT, Sadock BJ, editors. Comprehensive textbook of psychiatry VI, vol. 1. Baltimore: Williams and Wilkins. p 927-942.
